Atlas market file · Equity · United States
Park Dental Partners, Inc.PARK
- Last close
- 21.42
- Change
- +3.23%
- 96-bar range
- 15.556 – 22.675
- As of
- 6 Aug 2026
Park Dental Partners, Inc. is a services-misc health & allied services, nec issuer listed as PARK on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 37 weekly closes (+61.05% over the window).
Source rail: Yahoo Finance chart API (PARK). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for PARK. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
PARK public profile
Services-misc health & allied services, nec issuer. Park Dental Partners, Inc. is connected to current market context, cited company sources and its retained research file.
Park Dental Partners, Inc. trades as PARK on NASDAQ. Park Dental Partners, Inc. (PARK) has a latest verified close of 21.42, up 3.23%, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files PARK under USA Stocks and Healthcare & Medicine Stocks for browsing.
What changed for Park Dental Partners, Inc. today
Park Dental Partners, Inc. (PARK on the OTC but not on the NYSE) just filed its 10-Q for the quarter that ended 31 March 2026, and the numbers read like a dental chart left in the sun: $62.7 million in revenue, $390,000 net loss, negative nine-cent EPS, and $1.9 million of operating losses. The company describes itself as a ‘leading dental resource organisation’ that helps dentists ‘for their entire career,’ yet the cash ledger shows just $5 million from operations and $24.4 million in cash on hand-enough for a short fluoride rinse, not a long-term smile. (source: 10-Q, period ending 2026-03-31, SEC EDGAR, https://www.sec.gov/Archives/edgar/data/2069604/000110465926076105/xslF345X06/tm2618421-7_4seq1.xml)
Park Dental Partners markets a support model for general and multi-specialty dental groups, promising ‘a comprehensive team of experienced administrators and clinical leaders’ to help dentists meet professional goals. The product pitch is glossy, the website is sunny, and the company even offers a ‘contact us’ portal for inquiries-all of which is perfectly fine until you notice the balance sheet. Assets of $179.9 million sit opposite $154.4 million in liabilities, leaving just $25.4 million of equity to absorb any surprise root-canal bill. (source: 10-Q, period ending 2026-03-31, SEC EDGAR, https://www.sec.gov/Archives/edgar/data/2069604/000110465926076105/xslF345X06/tm2618421-7_4seq1.xml)
The company’s latest 10-Q lists $949,000 of inventory-mostly dental supplies-while capital expenditure for the quarter was $2.3 million and operating cash flow was $5 million, leaving a working capital burn that would make even the most stoic dentist flinch. Diluted EPS of negative nine cents and 4.4 million diluted shares suggest the ‘support organisation’ label is still in beta testing. Cash is there, but it’s not the kind that pays the bills with a smile; it’s the kind that sits in the bank waiting for the next set of obligations. (source: 10-Q, period ending 2026-03-31, SEC EDGAR, https://www.sec.gov/Archives/edgar/data/2069604/000110465926076105/xslF345X06/tm2618421-7_4seq1.xml)
If you want to see the company’s public face, the marketing site at parkdentalpartners.com shows bright imagery, clean copy, and an ‘affiliate practices’ map that implies scale and stability. The actual scale, however, is measured in $62.7 million of revenue and $25.4 million of equity-not the kind of numbers that justify the word ‘leading’ without inverted commas. The site also includes a ‘How Does a DSO Work?’ explainer, which is helpful until you realise the company’s own filings are doing the explaining for you. (source: Official product/news rail, https://parkdentalpartners.com)
The bylaws, adopted in October 2023, read like a corporate serenity prayer: ‘with respect’ appears twice in the space of a single paragraph, a cadence that feels aspirational given the red ink in the 10-Q. The firm’s governance boilerplate promises service ‘with respect’ while the balance sheet is respectfully haemorrhaging. There is no evidence in the filings that the board has waived its director fees to plug the hole, nor any indication that the ‘experienced administrators’ are moonlighting as liquidity providers. (source: Bylaws of Park Dental Partners, Inc., dated 2023-10-31, SEC EDGAR, https://www.sec.gov/Archives/edgar/data/2069604/000110465925086768/tm2514579d6_ex3-3.htm)
For investors chasing the ‘dental support organisation’ story, the mechanical facts are these: revenue is real, the losses are real, and the cash flow is real-but none of them are smiling. The company’s 10-Q is the only definitive source of truth; the website is aspirational marketing, the bylaws are aspirational governance, and the cash on hand is the only thing keeping the lights on at the support desk. Until the operating cash flow turns consistently positive or the liabilities shrink, the gap between promise and performance will keep widening like an unchecked gingival pocket. (source: 10-Q, period ending 2026-03-31, SEC EDGAR, https://www.sec.gov/Archives/edgar/data/2069604/000110465926076105/xslF345X06/tm2618421-7_4seq1.xml)
Sources & evidence · 10 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
PARK technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on PARK
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep PARK research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
PARK FAQ
What is Park Dental Partners, Inc. (PARK)?Park Dental Partners, Inc. (PARK) has a latest verified close of 21.42, up 3.23%, dated 6 Aug 2026. Use this page to check the price chart, company context,...
Park Dental Partners, Inc. (PARK) has a latest verified close of 21.42, up 3.23%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for PARK?Park Dental Partners, Inc. (PARK) has a latest verified close of 21.42, up 3.23%, dated 6 Aug 2026. It brings the latest available chart, company context, cited...
Park Dental Partners, Inc. (PARK) has a latest verified close of 21.42, up 3.23%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files PARK under USA Stocks and Healthcare & Medicine Stocks for browsing.
How often is the PARK page updated?The PARK public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The PARK public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for PARK?The PARK file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:PARK. SEC EDGAR provides the filing anchor for this issuer. The page separates...
The PARK file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:PARK. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on PARK?Yes. The workstation can open PARK, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open PARK, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this PARK page investment advice?No. The PARK page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The PARK page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
PARK
Equity · evidence first